연구동향 분석

Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine

최윤영 정재호 노성훈 2015년

논문상세정보
인용/피인용
' Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • gastric cancer
  • precision medicine
  • treatment
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,945 0

0.0%

' Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine' 의 참고문헌

  • What is the problem in clinical application of sentinel node concept to gastric cancer surgery?
    Miyashiro I J Gastric Cancer 12 : 7 ~ 12 [2012]
  • What Is the Problem in Clinical Application of Sentinel Node Concept to Gastric Cancer Surgery?
    Isao Miyashiro Journal of Gastric Cancer 12 1 7-12 [2012]
  • WHO Classification of Tumours of the Digestive System
    International Agency for Research on Cancer [2010]
  • Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
    Ribic CM N Engl J Med 349 : 247 ~ 257 [2003]
  • Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
    Ribic CM N Engl J Med 349 247-257 [2003]
  • Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer(ToGA) : a phase 3, open-label, randomised controlled trial
    Bang YJ Lancet 376 : 687 ~ 697 [2010]
  • Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
    Bang YJ Lancet 376 687-697 [2010]
  • Toward precision medicine: building a Knowledge network for biomedical research and a new taxonomy of disease
  • Toward precision medicine: building a Knowledge network for biomedical research and a new taxonomy of disease
  • The two histological main types of gastric carcinoma:diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification
    Lauren P Acta Pathol Microbiol Scand 64 31-49 [1965]
  • The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification
    Lauren P Acta Pathol Microbiol Scand 64 : 31 ~ 49 [1965]
  • The future of sentinel node oriented tailored approach in patients with early gastric cancer
    Ryu KW J Gastric Cancer 12 : 1 ~ 2 [2012]
  • The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer
    Oh SJ J Surg Oncol 99 : 275 ~ 280 [2009]
  • The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer
    Oh SJ J Surg Oncol 99 275-280 [2009]
  • The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: results from a large cohort with subgroup analyses
    Kim SY Int J Cancer 137 : 819 ~ 825 [2015]
  • The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: results from a large cohort with subgroup analyses
    Kim SY Int J Cancer 137 819-825 [2015]
  • The Japanese guidelines for gastric cancer screening
    Hamashima C Jpn J Clin Oncol 38 : 259 ~ 267 [2008]
  • The Japanese guidelines for gastric cancer screening
    Hamashima C Jpn J Clin Oncol 38 259-267 [2008]
  • The Future of Sentinel Node Oriented Tailored Approach in Patients with Early Gastric Cancer
    Keun Won Ryu Journal of Gastric Cancer 12 1 1-2 [2012]
  • Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients
    Kosuga T Gastric Cancer 14 : 172 ~ 177 [2011]
  • Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients
    Kosuga T Gastric Cancer 14 172-177 [2011]
  • Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
    Songun I Lancet Oncol 11 : 439 ~ 449 [2010]
  • Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
    Songun I Lancet Oncol 11 439-449 [2010]
  • Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus
    Mönig SP J Surg Oncol 76 : 89 ~ 92 [2001]
  • Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus
    Mönig SP J Surg Oncol 76 89-92 [2001]
  • Significance of long-term follow-up of early gastric cancer
    Kunisaki C Ann Surg Oncol 13 : 363 ~ 369 [2006]
  • Significance of long-term follow-up of early gastric cancer
    Kunisaki C Ann Surg Oncol 13 363-369 [2006]
  • Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan
    Kitagawa Y J Clin Oncol 31 : 3704 ~ 3710 [2013]
  • Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan
    Kitagawa Y J Clin Oncol 31 3704-3710 [2013]
  • Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis
    Marano A J Gastric Cancer 13 : 136 ~ 148 [2013]
  • Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis
    Alessandra Marano Journal of Gastric Cancer 13 3 136-148 [2013]
  • Robot-assisted gastrectomy with lymph node dissection for gastric cancer:lessons learned from an initial 100 consecutive procedures
    Song J Ann Surg 249 : 927 ~ 932 [2009]
  • Robot-assisted gastrectomy with lymph node dissection for gastric cancer:lessons learned from an initial 100 consecutive procedures
    Song J Ann Surg 249 927-932 [2009]
  • Robot-assisted gastrectomy for gastric cancer: current status and technical considerations
    Coratti A World J Surg 37 : 2771 ~ 2781 [2013]
  • Robot-assisted gastrectomy for gastric cancer: current status and technical considerations
    Coratti A World J Surg 37 2771-2781 [2013]
  • Rapid adaptation of robotic gastrectomy for gastric cancer by experienced laparoscopic surgeons
    Park SS Surg Endosc 26 : 60 ~ 67 [2012]
  • Rapid adaptation of robotic gastrectomy for gastric cancer by experienced laparoscopic surgeons
    Park SS Surg Endosc 26 60-67 [2012]
  • Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma:Japan clinical oncology group study JCOG 0110-MF
    Sano T Jpn J Clin Oncol 32 : 363 ~ 364 [2002]
  • Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma:Japan clinical oncology group study JCOG 0110-MF
    Sano T Jpn J Clin Oncol 32 363-364 [2002]
  • Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer
    Yu W Br J Surg 93 : 559 ~ 563 [2006]
  • Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer
    Yu W Br J Surg 93 559-563 [2006]
  • Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients
    Bonenkamp JJ Lancet 345 : 745 ~ 748 [1995]
  • Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients
    Bonenkamp JJ Lancet 345 745-748 [1995]
  • Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma(REGARD) : an international, randomised, multicentre, placebo-controlled, phase 3 trial
    Fuchs CS Lancet 383 : 31 ~ 39 [2014]
  • Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebocontrolled, phase 3 trial
    Fuchs CS Lancet 383 31-39 [2014]
  • Prediction of Cancer Incidence and Mortality in Korea, 2015
    정규원 Cancer Research and Treatment 47 (2) : 142 ~ 148 [2015]
  • Prediction of Cancer Incidence and Mortality in Korea, 2015
    정규원 Cancer Research and Treatment 47 2 142-148 [2015]
  • Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group
    Cuschieri A Lancet 347 : 995 ~ 999 [1996]
  • Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group
    Cuschieri A Lancet 347 995-999 [1996]
  • Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275)
    Engstrom PF Cancer 55 : 1868 ~ 1873 [1985]
  • Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275)
    Engstrom PF Cancer 55 1868-1873 [1985]
  • Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial
    Lee J J Clin Oncol 30 : 268 ~ 273 [2012]
  • Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial
    Lee J J Clin Oncol 30 268-273 [2012]
  • Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
    S. H. Park Journal of Clinical Oncology 33 (28) : 3130 ~ 3136 [2015]
  • Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
    S. H. Park Journal of Clinical Oncology 33 28 3130-3136 [2015]
  • Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
    Kreisl TN J Clin Oncol 27 : 740 ~ 745 [2009]
  • Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
    Kreisl TN J Clin Oncol 27 740-745 [2009]
  • Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma
    Shah MA J Clin Oncol 29 : 868 ~ 874 [2011]
  • Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma
    Shah MA J Clin Oncol 29 868-874 [2011]
  • Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    Cunningham D N Engl J Med 355 : 11 ~ 20 [2006]
  • Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    Cunningham D N Engl J Med 355 11-20 [2006]
  • Paving the Way for Personalized Medicine: FDA’s Role in a New Era of Medical Product Development
    US Food and Drug Administration US Department of Health And Human Services, FDA [2013]
  • Paving the Way for Personalized Medicine: FDA’s Role in a New Era of Medical Product Development
  • Patient survival after D1 and D2 resections for gastric cancer:long-term results of the MRC randomized surgical trial. Surgical Co-operative Group
    Cuschieri A Br J Cancer 79 : 1522 ~ 1530 [1999]
  • Patient survival after D1 and D2 resections for gastric cancer:long-term results of the MRC randomized surgical trial. Surgical Co-operative Group
    Cuschieri A Br J Cancer 79 1522-1530 [1999]
  • Pancreatosplenectomy for advanced gastric carcinoma with special reference to lymph nodes metastasis
    Ohashi I Jpn J Gastroenterol Surg 12 : 993 ~ 999 [1979]
  • Pancreatosplenectomy for advanced gastric carcinoma with special reference to lymph nodes metastasis
    Ohashi I Jpn J Gastroenterol Surg 12 993-999 [1979]
  • Pancreas-preserving total gastrectomy for proximal gastric cancer
    Maruyama K World J Surg 19 : 532 ~ 536 [1995]
  • Pancreas-preserving total gastrectomy for proximal gastric cancer
    Maruyama K World J Surg 19 532-536 [1995]
  • Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
    Sandler A N Engl J Med 355 : 2542 ~ 2550 [2006]
  • Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
    Sandler A N Engl J Med 355 2542-2550 [2006]
  • Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
    Gettinger SN J Clin Oncol 33 : 2004 ~ 2012 [2015]
  • Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
    Gettinger SN J Clin Oncol 33 2004-2012 [2015]
  • Nodal dissection for patients with gastric cancer: a randomised controlled trial
    Wu CW Lancet Oncol 7 : 309 ~ 315 [2006]
  • Nodal dissection for patients with gastric cancer: a randomised controlled trial
    Wu CW Lancet Oncol 7 309-315 [2006]
  • Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial)
    Kim HH Ann Surg 251 : 417 ~ 420 [2010]
  • Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial)
    Kim HH Ann Surg 251 417-420 [2010]
  • Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database
    Bartlett EK Surgery 156 : 298 ~ 304 [2014]
  • Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database
    Bartlett EK Surgery 156 298-304 [2014]
  • Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
    Cristescu R Nat Med 21 : 449 ~ 456 [2015]
  • Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
    Cristescu R Nat Med 21 449-456 [2015]
  • Minimally invasive surgery for gastric cancer treatment: current status and future perspectives
    Son T Gut Liver 8 : 229 ~ 236 [2014]
  • Minimally Invasive Surgery for Gastric Cancer Treatment: Current Status and Future Perspectives
    손태일 Gut and Liver 8 3 229-236 [2014]
  • Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection
    An JY Int J Cancer 131 : 505 ~ 511 [2012]
  • Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection
    An JY Int J Cancer 131 505-511 [2012]
  • Major early complications following open, laparoscopic and robotic gastrectomy
    Kim KM Br J Surg 99 : 1681 ~ 1687 [2012]
  • Major early complications following open, laparoscopic and robotic gastrectomy
    Kim KM Br J Surg 99 1681-1687 [2012]
  • Lymphadenectomy for gastric cancer
    Mansfield PF J Clin Oncol 22 : 2759 ~ 2761 [2004]
  • Lymphadenectomy for gastric cancer
    Mansfield PF J Clin Oncol 22 2759-2761 [2004]
  • Long Longterm results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study
    Kim HH J Clin Oncol 32 : 627 ~ 633 [2014]
  • Long Longterm results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study
    Kim HH J Clin Oncol 32 627-633 [2014]
  • Laparoscopy-assisted Billroth I gastrectomy
    Kitano S Surg Laparosc Endosc 4 : 146 ~ 148 [1994]
  • Laparoscopy-assisted Billroth I gastrectomy
    Kitano S Surg Laparosc Endosc 4 146-148 [1994]
  • Laparoscopic gastrectomy for advanced gastric cancer: are the long-term results comparable with conventional open gastrectomy? A systematic review and meta-analysis
    Choi YY J Surg Oncol 108 : 550 ~ 556 [2013]
  • Laparoscopic gastrectomy for advanced gastric cancer: are the long-term results comparable with conventional open gastrectomy? A systematic review and meta-analysis
    Choi YY J Surg Oncol 108 550-556 [2013]
  • Japanese gastric cancer treatment guidelines 2010
    Japanese Gastric Cancer Association Gastric Cancer 14 : 113 ~ 123 [2011]
  • Japanese gastric cancer treatment guidelines 2010
    Japanese Gastric Cancer Association Gastric Cancer 14 113-123 [2011]
  • Japanese Classification of Gastric Carcinoma: 2nd English edition
    Japanese Gastric Cancer Association Gastric Cancer 1 10-24 [1998]
  • Japanese Classification of Gastric Carcinoma : 2nd English edition
    Japanese Gastric Cancer Association Gastric Cancer 1 : 10 ~ 24 [1998]
  • Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis
    Choi YY J Surg Oncol 110 : 129 ~ 135 [2014]
  • Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis
    Choi YY J Surg Oncol 110 129-135 [2014]
  • Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy
    Tan IB Gastroenterology 141 : 476 ~ 485 [2011]
  • Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy
    Tan IB Gastroenterology 141 476-485 [2011]
  • Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers
    Gotoda T Gastric Cancer 3 : 219 ~ 225 [2000]
  • Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers
    Gotoda T Gastric Cancer 3 219-225 [2000]
  • Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer
    Lee KY Ann Surg Oncol 8 : 402 ~ 406 [2001]
  • Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer
    Lee KY Ann Surg Oncol 8 402-406 [2001]
  • Genetic basis for clinical response to CTLA-4 blockade in melanoma
    Snyder A N Engl J Med 371 : 2189 ~ 2199 [2014]
  • Genetic basis for clinical response to CTLA-4 blockade in melanoma
    Snyder A N Engl J Med 371 2189-2199 [2014]
  • Gene expression signature-based prognostic risk score in gastric cancer
    Cho JY Clin Cancer Res 17 : 1850 ~ 1857 [2011]
  • Gene expression signature-based prognostic risk score in gastric cancer
    Cho JY Clin Cancer Res 17 1850-1857 [2011]
  • Gastrointestinal cancer: targeted therapies in gastric cancer-the dawn of a new era
    Shah MA Nat Rev Clin Oncol 11 : 10 ~ 11 [2014]
  • Gastrointestinal cancer: targeted therapies in gastric cancer-the dawn of a new era
    Shah MA Nat Rev Clin Oncol 11 10-11 [2014]
  • Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Waddell T Ann Oncol 24 (Suppl 6) : vi57 ~ vi63 [2013]
  • Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Waddell T Ann Oncol 24 Suppl 6 vi57-vi63 [2013]
  • Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines
    Ajani JA J Natl Compr Canc Netw 11 : 531 ~ 546 [2013]
  • Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines
    Ajani JA J Natl Compr Canc Netw 11 531-546 [2013]
  • Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501
    Sano T J Clin Oncol 22 : 2767 ~ 2773 [2004]
  • Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501
    Sano T J Clin Oncol 22 2767-2773 [2004]
  • Gastric Cancer Screening in Korea: Report on the National Cancer Screening Program in 2008
    이경숙 Cancer Research and Treatment 43 (2) : 83 ~ 88 [2011]
  • Gastric Cancer Screening in Korea: Report on the National Cancer Screening Program in 2008
    이경숙 Cancer Research and Treatment 43 2 83-88 [2011]
  • Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer
    Sasada S Anticancer Res 29 : 3347 ~ 3351 [2009]
  • Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer
    Sasada S Anticancer Res 29 3347-3351 [2009]
  • Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer
    Sasako M J Clin Oncol 29 : 4387 ~ 4393 [2011]
  • Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer
    Sasako M J Clin Oncol 29 4387-4393 [2011]
  • Extended lymph-node dissection for gastric cancer
    Bonenkamp JJ N Engl J Med 340 : 908 ~ 914 [1999]
  • Extended lymph-node dissection for gastric cancer
    Bonenkamp JJ N Engl J Med 340 908-914 [1999]
  • Extended local resection for advanced gastric cancer: increased survival versus increased morbidity
    Martin RC 2nd Ann Surg 236 : 159 ~ 165 [2002]
  • Extended local resection for advanced gastric cancer: increased survival versus increased morbidity
    Martin RC 2nd Ann Surg 236 159-165 [2002]
  • Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
    Wang K Nat Genet 43 : 1219 ~ 1223 [2011]
  • Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
    Wang K Nat Genet 43 1219-1223 [2011]
  • Endoscopic mucosal resection for treatment of early gastric cancer
    Ono H Gut 48 : 225 ~ 229 [2001]
  • Endoscopic mucosal resection for treatment of early gastric cancer
    Ono H Gut 48 225-229 [2001]
  • East meets west in the treatment of gastric cancer
    Cunningham D N Engl J Med 357 : 1863 ~ 1865 [2007]
  • East meets west in the treatment of gastric cancer
    Cunningham D N Engl J Med 357 1863-1865 [2007]
  • Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer
    Boussioutas A Cancer Res 63 : 2569 ~ 2577 [2003]
  • Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer
    Boussioutas A Cancer Res 63 2569-2577 [2003]
  • Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
    Sargent DJ J Clin Oncol 28 : 3219 ~ 3226 [2010]
  • Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
    Sargent DJ J Clin Oncol 28 3219-3226 [2010]
  • D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer
    Sasako M N Engl J Med 359 : 453 ~ 462 [2008]
  • D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer
    Sasako M N Engl J Med 359 453-462 [2008]
  • Current practice of gastric cancer treatment
    Choi YY Chin Med J (Engl) 127 : 547 ~ 553 [2014]
  • Current practice of gastric cancer treatment
    Choi YY Chin Med J (Engl) 127 547-553 [2014]
  • Comprehensive molecular characterization of gastric adenocarcinoma
    Cancer Genome Atlas Research Network Nature 513 : 202 ~ 209 [2014]
  • Comprehensive molecular characterization of gastric adenocarcinoma
    Cancer Genome Atlas Research Network Nature 513 202-209 [2014]
  • Comparison of quality of life and worry of cancer recurrence between endoscopic and surgical treatment for early gastric cancer
    Choi JH Gastrointest Endosc [2015]
  • Comparison of quality of life and worry of cancer recurrence between endoscopic and surgical treatment for early gastric cancer
    Choi JH Gastrointest Endosc - [2015]
  • Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
    Macdonald JS N Engl J Med 345 : 725 ~ 730 [2001]
  • Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
    Macdonald JS N Engl J Med 345 725-730 [2001]
  • Changes in Treatment Outcomes of Gastric Cancer Surgery Over 45 Years at A Single Institution
    형우진 Yonsei Medical Journal 49 (3) : 409 ~ 415 [2008]
  • Changes in Treatment Outcomes of Gastric Cancer Surgery Over 45 Years at A Single Institution
    형우진 Yonsei Medical Journal 49 3 409-415 [2008]
  • Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
    Ferlay J Int J Cancer 136 : E359 ~ E386 [2015]
  • Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
    Ferlay J Int J Cancer 136 E359-E386 [2015]
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012
    정규원 Cancer Research and Treatment 47 (2) : 127 ~ 141 [2015]
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012
    정규원 Cancer Research and Treatment 47 2 127-141 [2015]
  • Cancer JRSfG: Japenese classification of gastric carcinoma
    Kanehara [1995]
  • Cancer JRSfG: Japenese classification of gastric carcinoma
    - [1995]
  • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    Hurwitz H N Engl J Med 350 : 2335 ~ 2342 [2004]
  • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    Hurwitz H N Engl J Med 350 2335-2342 [2004]
  • Bevacizumab in combination with chemotherapy as firstline therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial
    Van Cutsem E J Clin Oncol 30 : 2119 ~ 2127 [2012]
  • Bevacizumab in combination with chemotherapy as firstline therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial
    Van Cutsem E J Clin Oncol 30 2119-2127 [2012]
  • Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study
    Ohtsu A J Clin Oncol 29 3968-3976 [2011]
  • Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer : a randomized, double-blind, placebo-controlled phase III study
    Ohtsu A J Clin Oncol 29 : 3968 ~ 3976 [2011]
  • Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis
  • Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis
  • Advanced gastric cancer: is chemotherapy needed after surgery?
    Choi YY Expert Rev Gastroenterol Hepatol 7 : 673 ~ 675 [2013]
  • Advanced gastric cancer: is chemotherapy needed after surgery?
    Choi YY Expert Rev Gastroenterol Hepatol 7 673-675 [2013]
  • Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group
    Nakajima T Lancet 354 : 273 ~ 277 [1999]
  • Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group
    Nakajima T Lancet 354 273-277 [1999]
  • Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study
    Macdonald JS Ann Surg Oncol 2 : 488 ~ 494 [1995]
  • Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study
    Macdonald JS Ann Surg Oncol 2 488-494 [1995]
  • Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
    Sakuramoto S N Engl J Med 357 : 1810 ~ 1820 [2007]
  • Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
    Sakuramoto S N Engl J Med 357 1810-1820 [2007]
  • Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
    Noh SH Lancet Oncol 15 : 1389 ~ 1396 [2014]
  • Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
    Noh SH Lancet Oncol 15 1389-1396 [2014]
  • Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
    Bang YJ Lancet 379 : 315 ~ 321 [2012]
  • Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
    Bang YJ Lancet 379 315-321 [2012]
  • A prospective, randomized evaluation of intensivecourse 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer
    Krook JE Cancer 67 : 2454 ~ 2458 [1991]
  • A prospective, randomized evaluation of intensivecourse 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer
    Krook JE Cancer 67 2454-2458 [1991]
  • A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer
    Cai J Dig Surg 28 : 331 ~ 337 [2011]
  • A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer
    Cai J Dig Surg 28 331-337 [2011]
  • A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric Cancer (JCOG0912)
    Nakamura K Jpn J Clin Oncol 43 : 324 ~ 327 [2013]
  • A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric Cancer (JCOG0912)
    Nakamura K Jpn J Clin Oncol 43 324-327 [2013]
  • A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer
    Lian J Gastrointest Endosc 76 : 763 ~ 770 [2012]
  • A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer
    Lian J Gastrointest Endosc 76 763-770 [2012]